We are live on ! Find out more
ARMC

American Research & Management Company Portfolio holdings

AUM $362M
1-Year Est. Return 8.06%
This Fund
S&P 500
This Quarter Est. Return
+14.25%
1 Year Est. Return
-8.06%
3 Year Est. Return
+35.06%
5 Year Est. Return
+60.88%
10 Year Est. Return
AUM
$351M
AUM Growth
+$53.8M
Cap. Flow
+$14.7M
Cap. Flow %
4.2%
Top 10 Hldgs %
34.35%
Holding
384
New
50
Increased
68
Reduced
47
Closed
5

Top Buys

Rank Stock Value
1
FDX icon
FedEx
FDX
+$1.36M
2
AMLP icon
Alerian MLP ETF
AMLP
+$1.16M
3
NVDA icon
NVIDIA
NVDA
+$772K
4
CVX icon
Chevron
CVX
+$449K
5
MSFT icon
Microsoft
MSFT
+$389K

Top Sells

Rank Stock Value
1
IBM icon
IBM
IBM
+$448K
2
FISV
Fiserv Inc
FISV
+$271K
3
ADBE icon
Adobe
ADBE
+$253K
4
ADP icon
Automatic Data Processing
ADP
+$189K
5
WAT icon
Waters Corp
WAT
+$145K

Sector Composition

Rank Sector Weight
1 Technology 23.61%
2 Healthcare 15.03%
3 Consumer Staples 14.5%
4 Miscellaneous 12.1%
5 Financials 9.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EA
326
DELISTED
Electronic Arts
EA
$5K ﹤0.01%
45
EMD
327
Western Asset Emerging Markets Debt Fund
EMD
$613M
$5K ﹤0.01%
400
GSG icon
328
iShares S&P GSCI Commodity-Indexed Trust
GSG
$967M
$5K ﹤0.01%
300
RGR icon
329
Sturm, Ruger & Co
RGR
$595M
$5K ﹤0.01%
100
SNV
330
DELISTED
Synovus
SNV
$5K ﹤0.01%
+142
New +$5.21K
JJC
331
DELISTED
iPath Bloomberg Copper Subindex Total Return ETN due October 22, 2037
JJC
$5K ﹤0.01%
150
AGN
332
DELISTED
Allergan Inc
AGN
$5K ﹤0.01%
33
AGNC icon
333
AGNC Investment
AGNC
$12.9B
$4K ﹤0.01%
200
AMBA icon
334
Ambarella
AMBA
$3.1B
$4K ﹤0.01%
100
CNI icon
335
Canadian National Railway
CNI
$76.2B
$4K ﹤0.01%
50
CVE icon
336
Cenovus Energy
CVE
$58.2B
$4K ﹤0.01%
500
FSLR icon
337
First Solar
FSLR
$22B
$4K ﹤0.01%
80
HOG icon
338
Harley-Davidson
HOG
$2.92B
$4K ﹤0.01%
100
ROK icon
339
Rockwell Automation
ROK
$47.8B
$4K ﹤0.01%
25
SLV icon
340
iShares Silver Trust
SLV
$32.3B
$4K ﹤0.01%
300
UPS icon
341
United Parcel Service
UPS
$89.6B
$4K ﹤0.01%
35
YUMC icon
342
Yum China
YUMC
$15.3B
$4K ﹤0.01%
80
OPNT
343
DELISTED
Opiant Pharmaceuticals, Inc. Common Stock
OPNT
$4K ﹤0.01%
300
ACAD icon
344
Acadia Pharmaceuticals
ACAD
$5.02B
$3K ﹤0.01%
100
BX icon
345
Blackstone
BX
$107B
$3K ﹤0.01%
100
CMRE icon
346
Costamare
CMRE
$1.86B
$3K ﹤0.01%
500
HACK icon
347
Amplify Cybersecurity ETF
HACK
$2.97B
$3K ﹤0.01%
63
NFLX icon
348
Netflix
NFLX
$340B
$3K ﹤0.01%
90
RIG icon
349
Transocean
RIG
$6.48B
$3K ﹤0.01%
+316
New +$2.71K
SYF icon
350
Synchrony
SYF
$25.4B
$3K ﹤0.01%
98

Similar funds

American Research & Management Company's Q1 2019 Portfolio in Review

As of Q1 2019, American Research & Management Company held 384 positions worth $351M, up 18% from $297M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

American Research & Management Company deployed $14.7M of net new capital in Q1 2019, opening 50 new positions and adding to 68 existing holdings. Its largest new stake was Marathon Petroleum: 4,535 shares worth $271K.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Staples.

On the sell side, the largest reduction was IBM, an estimated $448K trimmed.

  • American Research & Management Company's largest Q1 2019 buy was Marathon Petroleum: 4,535 shares worth $271K.
  • American Research & Management Company added most to FedEx in Q1 2019, an estimated $1.36M increase.
  • American Research & Management Company's biggest Q1 2019 reduction was IBM, cutting an estimated $448K.
  • American Research & Management Company fully exited Access National Corp in Q1 2019, selling an estimated $126K.
  • American Research & Management Company's ten largest holdings make up 34% of its $351M portfolio in Q1 2019.
  • American Research & Management Company opened 50 new positions and closed 5 in Q1 2019.
  • American Research & Management Company's portfolio value rose 18% quarter-over-quarter to $351M.

Based on American Research & Management Company's 13F filing for Q1 2019, filed 16 Apr 2019.